An Assessment of Biological Potency and Molecular Characteristics of Different Innovator and Noninnovator Interferon-Beta Products-Reference-Cited by-同舟云学术

An Assessment of Biological Potency and Molecular Characteristics of Different Innovator and Noninnovator Interferon-Beta Products

Published:2011-04 Issue:4 Volume:31 Page:383-392
ISSN:1079-9907
Container-title:Journal of Interferon & Cytokine Research
language:en
Short-container-title:Journal of Interferon & Cytokine Research

Author:

Meager Anthony¹,Dolman Carl¹,Dilger Paula¹,Bird Chris¹,Giovannoni Gavin²,Schellekens Huub³,Thorpe Robin¹,Wadhwa Meenu¹

Affiliation:

1. Cytokine and Growth Factor Section, Biotherapeutics Group, National Institute for Biological Standards and Control, Hertfordshire, United Kingdom.

2. Department of Neurology, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.

3. Department of Pharmaceutical Sciences and Innovation Studies, Utrecht University, Utrecht, The Netherlands.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Cell Biology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jir.2010.0113

Reference39 articles.

1. Structure−Function Engineering of Interferon-β-1b for Improving Stability, Solubility, Potency, Immunogenicity, and Pharmacokinetic Properties by Site-Selective Mono-PEGylation

2. Focal Cortical Dysplasia

3. Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin

4. Interferon-β1afor the treatment of multiple sclerosis

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Toxicity of Interferon Beta-1a Impurities of Heavy Metal Ions;Medicina;2022-03-23

2. Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review;European Journal of Pharmaceutical Sciences;2020-11

3. The Breakthrough of Biosimilars: A Twist in the Narrative of Biological Therapy;Biomolecules;2019-08-24

5. Multiplexed Gene Expression as a Characterization of Bioactivity for Interferon Beta (IFN-β) Biosimilar Candidates: Impact of Innate Immune Response Modulating Impurities (IIRMIs);The AAPS Journal;2019-02-08